Did Reformulated OxyContin Really Discourage Abuse?

(MedPage Today) -- An FDA advisory panel will vote later this week on whether or not Purdue Pharma's abuse-deterrent formulation (ADF) of oxycodone (OxyContin) "meaningfully reduced" opioid-related overdoses and deaths since it reached market 10...